DailyIQ
Last updatedUpdating…

LDOS·Leidos Holdings, Inc.

$119.50
-0.20 (-0.17%)
High
$121.88
Open
$119.50
Market Cap
15.23B
52W High
$205.77
Low
$119.10
P. Close
$119.50
P/E
11.07
52W Low
$98.86
Fwd P/E
9.50
DailyIQ Est.
$155.69
Inst. Ownership
39.4%
Short Interest
3.83%
Days to Cover
3.5
Div. Yield
1.44%
Next Ex-Div
~Dec 15
Div. Growth
7+ yrs
Technical Score (1D)
10
BEARISH
News Sentiment
67
BULLISH
On Oct 13, Leidos Holdings announced it had secured a $317.9 million contract from the U.S. Defense Health Agency to provide system reintegration, software licensing, and hosting services for the MHS Genesis electronic health record system. The agreement, effective July 29 and running through Jan 28 2028, will be performed in Reston, Virginia, and is designed to reduce scope over the 12‑month period while easing transition to other contractors, reinforcing Leidos’s position in defense‑related health IT services. On the same day, the company’s shares fell 1.56 percent, trailing the broader market, as investors reacted to the news. The decline followed an 8.45 percent month‑to‑date drop, and analysts noted that Leidos’s quarterly earnings guidance of $3.09 per share and a revenue forecast of $4.71 billion, a 5.29 percent year‑over‑year increase, offered only modest upside potential. The company’s guidance was only slightly above last year’s figures, suggesting limited upside potential, and investors were awaiting the November 3 earnings announcement for clearer direction.
LOW TARGET
$127 +6.3%
3 analysts
MEAN TARGET
$152 +27.0%
12 analysts
HIGH TARGET
$225 +88.3%
12 analysts
PRICE RANGE
$127.00 - $225.00
SB / B / H / S / SS
4/8/13/1/1
DAILYIQ EST.
$155.69 (+30.3%)
Sector
Technology
Industry
Information Technology Services
Exchange
NYQ
Country
United States
Website
Symbol
LDOS
Description
Leidos Holdings, Inc. is a provider of technology-driven solutions and services, primarily for government and commercial clients both domestically and internationally. The company's core business revolves around supporting critical missions through a diverse portfolio, including national security, digital modernization, and healthcare IT solutions. Leidos offers a range of services encompassing intelligence analysis, cybersecurity, logistics, and operational support, leveraging technologies like artificial intelligence and machine learning. Furthermore, the company's offerings extend to civil infrastructure, health systems, and international markets, providing specialized solutions for air traffic control, border security, and energy management. Founded in 1969, Leidos is headquartered in Reston, Virginia, and is a significant player in the defense and technology sectors.
Bought (1Y)
0 shares
$0
Sold (1Y)
25,260 shares
$3.2M
KRAEMER HARRY M JANSEN JR-
Award/Grant297.226 shares2026-10-07
SHAPARD ROBERT S-
Award/Grant5.701 shares2026-09-30
KRAEMER HARRY M JANSEN JR-
Award/Grant463.07 shares2026-09-30
Stevens Roy ESector President
Award/Grant6.394 shares2026-09-30
Cage Christopher RChief Financial Officer
Award/Grant92.778 shares2026-09-30
70/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
8.5%
Revenue CAGR
3.6%
Current Ratio
1.70x
Debt / Equity
0.95x
Return on Equity
29.5%
Earnings Summary
Leidos Holdings, Inc. is a technology‑driven solutions provider serving government and commercial clients worldwide, with a focus on national security, digital modernization, and healthcare IT. Operating in the information technology services sector, Leidos delivers intelligence analysis, cybersecurity, logistics, and operational support, leveraging AI and machine learning across defense, civil infrastructure, and health systems. In recent quarters, Leidos has consistently outperformed earnings estimates while maintaining revenue growth, reflecting its diversified portfolio and strong contract base. Q4 2024 saw EPS of $2.37 versus an estimate of $2.27 and revenue of $4.365 billion; Q1 2025 EPS rose to $2.97 against $2.50, with revenue slightly down to $4.245 billion. Q2 2025 EPS accelerated to $3.21 versus $2.66, and revenue remained flat at $4.253 billion, while Q3 2025 EPS of $3.05 beat the $2.72 estimate and revenue climbed to $4.469 billion. The company then experienced a revenue dip in Q4 2025 to $4.207 billion, below the $4.378 billion estimate, and EPS of $2.76 versus $2.96. Q1 2026 reversed the trend with EPS of $3.13 beating the $2.91 estimate and revenue of $4.400 billion surpassing the $4.287 billion estimate; Q2 2026 continued the upside with EPS of $3.26 versus $2.97 and revenue of $4.558 billion versus a $4.526 billion estimate. Historically, Leidos has shown a steady YoY revenue growth trajectory, with EPS consistently beating analyst expectations in the last six quarters, though revenue has occasionally lagged behind estimates during periods of contract adjustments. Recent news highlights the closure of a security screening joint venture, potentially reducing automation revenue, while the company’s Australian Mission Equipment Service Centre received a MRO Business of the Year award, underscoring operational excellence. Analysts have adjusted price targets downward, reflecting concerns about valuation and competitive pressures.

EPS

EstBeatMiss
$2.57$2.76$2.96$3.15$3.35Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$3.04 - -
Q2'26$2.97$3.26+9.9%
Q1'26$2.91$3.13+7.6%
Q4'25$2.96$2.76-6.9%
Q3'25$2.72$3.05+12.3%
Q2'25$2.66$3.21+20.8%

Revenue

EstBeatMiss
$4.1B$4.3B$4.5B$4.7B$4.9BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$4.8B - -
Q2'26$4.5B$4.6B+0.7%
Q1'26$4.3B$4.4B+2.6%
Q4'25$4.4B$4.2B-3.9%
Q3'25 - $4.5B -
Q2'25 - $4.3B -

Market Data

LDOS Stock Snapshot

BEARISH10/100
$119.50−$0.20 (0.2%)
Market cap
15.23B
P/E ratio
11.1
Day range
$119.10 – $121.88
News sentiment
67/100 · Bullish
Analyst target
$151.73 (+27.0%)
Consensus
Hold · 27 analysts
52-week range+20.9% off low · -41.9% from high
$98.86$205.77
Price $119.50 DailyIQ Est. $155.69

LDOS's technical picture is under pressure, with momentum working against price. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.

Reverse DCF

What growth is priced into LDOS?

CHEAP

At today's price, Leidos Holdings, Inc. needs to grow free cash flow about -9.6% a year for the next 10 years to justify its valuation at a 7.66% cost of capital. Over its actual history it has compounded free cash flow at 8.0% a year, so the market is asking for 17.6 percentage points below its own delivered rate. On that basis LDOS looks priced below what its own growth record supports.

Implied FCF growth
-9.6%
Historical FCF CAGR
8.0%
Growth gap
-17.6 pts
Verdict
CHEAP
Discount rate (WACC)
7.66%
Beta
0.64

Behaviour On Record

What LDOS's own history says about today's numbers

Realized volatility (21d)
36.1% 83rd pct
Below its peak
-40.6%
vs 200-day average
-17.7%
Up days (1y)
47%

Leidos Holdings, Inc. is currently running 36.1% annualised volatility over the last 21 sessions. Measured against LDOS's own 13 years of daily returns rather than a market-wide average, that is the 83rd percentile — elevated for this stock, against a typical reading of 22.5%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

LDOS is trading -40.6% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -26.9%, and the deepest was -44.0% in 2020. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -17.7% from its 200-day moving average. Against every other day in its history, that gap ranks at the 4th percentile — a narrower gap than it typically runs. Over the past year LDOS closed higher on 47% of sessions, and it is currently 2 sessions into a falling streak.

On October specifically: over 13 years of records, LDOS finished the month higher 9 of 13 times, with a median return of +3.1% and an average of +4.4%. Its strongest month historically has been October at +4.4% on average, its weakest March at -3.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: LDOS has opened more than 2% away from the prior close in 105 of 3,267 sessions (3.2% of the time), with the largest gaps running +10.3% and -26.1%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, LDOS moved an average of 3.4% in the session after earnings, closing higher 1 of those 3 times, with a median move of -1.7% and a largest of +5.2%.

All figures computed from 3,268 daily closes between 2013-10-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against LDOS's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of LDOS's sector?

Leidos Holdings, Inc. sits in the Software sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (weakening).

Sector rank
#2 of 12
Sector state
Weakening
Sector rotation score
73

Options Market

What is the options market pricing for LDOS?

CallsPuts

For Leidos Holdings, Inc.'s nearest expiry (2026-10-16, 2 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.15), with at-the-money implied volatility around 54.6%. The options market is pricing roughly a ±4.8% move by that expiry — a range of about $113.92–$125.40.

Put/call ratio (2026-10-16)
0.15
ATM implied volatility
54.6%
Total open interest
1,710
Expected move by 2026-10-16
±4.8% ($113.92–$125.40)

Analyst Rating Changes

Are analysts turning bullish or bearish on LDOS?

JP Morgan most recently downgraded Leidos Holdings, Inc. to Neutral on Oct 8, 2026 with a price target of $142 (from $160). Over the last 90 days, coverage has run 0 upgrades against 1 downgrade, a net bearish lean.

Latest action
JP Morgan — Neutral
90-day upgrades
0
90-day downgrades
1
Net rating momentum
-1
DateFirmActionRatingPrice target
Oct 8, 2026JP MorganDowngradeOverweight → Neutral$160 → $142
Oct 7, 2026CitigroupMaintainedBuy$161 → $141
Oct 6, 2026JefferiesMaintainedHold$145 → $130
Oct 6, 2026TD CowenMaintainedHold$135 → $130
Sep 18, 2026B of A SecuritiesMaintainedNeutral$125 → $135
Aug 12, 2026Goldman SachsMaintainedNeutral$152 → $132
Aug 11, 2026CitigroupMaintainedBuy$138 → $161
Aug 7, 2026TD CowenMaintainedHold$115 → $135
Aug 5, 2026UBSMaintainedNeutral$124 → $138
Aug 5, 2026BNP ParibasMaintainedOutperform$165 → $175
Aug 5, 2026RBC CapitalMaintainedOutperform$180 → $170
Jul 14, 2026Goldman SachsMaintainedNeutral$171 → $152

Peers & ETF holders

LDOS peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

67/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Leidos (LDOS) received a one‑year extension to its Logistics Commodities and Services Transformation contract with the UK Ministry of Defence, extending service through June 2029. The extension builds on a decade of collaboration and will maintain Leidos’ role in managing over 70,000 NATO stock numbers, supporting 600+ distribution locations, and delivering an estimated £400 million in benefits. The contract reinforces Leidos’ position in defence logistics, enhancing supply‑chain resilience, inventory visibility, and digital capabilities for the UK armed forces.
What did this article say?
Leidos Holdings (LDOS) won a $317.9 million contract from the U.S. Defense Health Agency to provide system reintegration, software licensing, and hosting services for the MHS Genesis electronic health record system. The agreement, effective July 29 and running through January 28, 2028, will be performed in Reston, Virginia, and is designed to reduce scope over the 12‑month period while easing transition to other contractors. The deal represents a significant revenue source for LDOS and reinforces its position in defense‑related health IT services.
What did this article say?
Leidos (LDOS) closed at $119.70 on October 13, falling 1.56% and trailing the broader market. The company’s stock has slid 8.45% over the past month, lagging the technology sector’s gains. Analysts project a modest earnings increase of 1.31% for the upcoming quarter, with revenue expected to grow 5.29% year‑over‑year. Despite the short‑term decline, the earnings outlook remains slightly positive, suggesting limited upside potential in the near term.
What did this article say?
Leidos Holdings announced the closure of its security screening joint venture with Altaris, potentially impacting its automation operations. The company also celebrated Leidos Australia’s Mission Equipment Service Centre receiving the MRO Business of the Year award, underscoring its defense support capabilities. The joint venture exit may reduce revenue streams, while the award highlights operational strengths. Together, these developments suggest a mixed outlook for the firm.
What did this article say?
JPMorgan reduced Leidos Holdings’ rating from overweight to neutral and lowered its price target to $142. The downgrade reflects concerns about the company’s valuation relative to earnings and the competitive environment. The decision signals a reassessment of Leidos’ growth prospects and may influence investor sentiment.
What did this article say?
JP Morgan analyst Seth Seifman downgraded Leidos Holdings (NYSE:LDOS) from Overweight to Neutral on October 8, citing concerns that the company’s earnings outlook had weakened. The firm also reduced its price target from $160 to $142, signaling a more cautious view of future growth prospects. The downgrade reflects a reassessment of Leidos’ competitive position and potential margin pressure in the defense and technology services sector.
What did this article say?
Leidos Holdings reported solid earnings while securing new defense and AI‑driven cyber contracts, reinforcing its revenue base. The company’s share price, however, had fallen 42.1% over the past year, prompting investors to question whether the current valuation aligns with earnings. Analysts noted that the recent contract wins could sustain profitability, but the market remains cautious about the stock’s fair value. The narrative highlights a mild headwind as the market reassesses the company’s valuation relative to its earnings performance.
What did this article say?
Citigroup analyst John Godyn kept a Buy recommendation for Leidos Holdings (LDOS) but reduced the price target from $161 to $141. The downgrade reflects concerns over the company’s earnings outlook and competitive pressures in the defense and technology sectors. The firm noted that Leidos’ revenue growth has slowed and that margin compression could limit future profitability. This adjustment signals a more cautious view on the stock’s upside potential.
What did this article say?
Leidos Australia announced that its Mission Equipment Service Centre (MESC) was named MRO Business of the Year at the 2026 Australian Aviation Awards. The award recognized the centre’s critical role in maintaining mission‑critical aircraft systems for national security, emergency response and defence across Australia and the Asia‑Pacific. The MESC, based in Cairns, is the only sovereign facility of its kind in the Southern Hemisphere, providing advanced maintenance, repair and overhaul for complex radar, electro‑optical, avionics and integrated mission systems. The recognition underscores Leidos’ leadership in technical excellence and its contribution to aircraft availability and mission readiness.

Technical Analysis

Real-time indicators across multiple timeframes

10
BEARISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $6.19B combined position · 12 adding, 13 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▼ Sell14,942,73411.96%$2.70B2026-01-29
BlackRock, Inc.▲ Buy9,948,8797.96%$1.02B2026-08-07
JPMorgan Chase & Co▼ Sell3,833,3523.07%$385.02M2026-08-12
Geode Capital Management, LLC▲ Buy3,672,0302.94%$376.79M2026-08-12
Invesco Ltd.▲ Buy3,138,2012.51%$323.14M2026-08-14
Morgan Stanley▲ Buy1,792,7471.44%$184.60M2026-08-13
FMR LLC (Fidelity)▼ Sell1,731,4091.39%$178.28M2026-08-13
Norges Bank▼ Sell1,708,0781.37%$175.88M2026-08-12
Goldman Sachs Group Inc▲ Buy1,695,8721.36%$174.62M2026-08-14
Northern Trust Corp▼ Sell1,072,0720.86%$110.39M2026-08-13
AQR Capital Management LLC▼ Sell826,5070.66%$83.47M2026-08-14
Bank of America Corp▼ Sell753,8410.60%$77.62M2026-08-14
Citadel Advisors LLC▲ Buy613,6320.49%$63.19M2026-09-02
Millennium Management LLC▲ Buy604,0470.48%$62.20M2026-08-14
AllianceBernstein L.P.▼ Sell388,4230.31%$60.41M2026-08-14
Neuberger Berman Group LLC▲ Buy410,1200.33%$42.23M2026-08-13
Citigroup Inc▲ Buy400,1880.32%$41.21M2026-08-03
Wells Fargo & Company▼ Sell300,3150.24%$30.92M2026-08-14
Gotham Asset Management, LLC▼ Sell184,6060.15%$19.01M2026-08-14
Two Sigma Investments, LP▼ Sell184,1420.15%$18.96M2026-08-14
Bridgewater Associates, LP▲ Buy158,6690.13%$16.34M2026-08-14
Squarepoint Ops LLC▼ Sell149,5240.12%$15.40M2026-08-14
Adage Capital Partners GP, L.L.C.▲ Buy124,9840.10%$12.87M2026-08-14
Verition Fund Management LLC▲ Buy102,3680.08%$10.54M2026-08-14
Man Group plc▼ Sell92,9560.07%$9.57M2026-08-14
Q2 2026 flow:2.54M sh bought ($261.61M)2.78M sh sold ($351.09M)net -238.8K sh (−$89.48M)
Congressional Trading Activity
3 disclosed trades · ~$48.5K est. traded value · 0 buys, 3 sells
MemberChamberStateTypeAmountTradedFiled
Alan ArmstrongSenateOK▼ Sell$15K - $50K2026-03-272026-07-21
Gerald E. ConnollyHouseVA11▼ Sell$1K - $15K2025-05-132025-05-17
Gerald E. ConnollyHouseVA11▼ Sell$1K - $15K2025-02-052025-02-06